Finance

Lists
31R:FRA
Revive Therapeutics Ltd
€ 0.0075
0.00%
(0.00) 1D
10-р сарын 2, 22:00:00 (GMT+2)  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 31R...
Open
€ 0.01
High
€ 0.01
Low
€ 0.01
Mkt. cap
8.72 сая
Avg. vol.
2.94 мян
Volume
0.00
52-wk high
€ 0.06
52-wk low
€ 0.00
Open
€ 0.01
High
€ 0.01
Low
€ 0.01
Mkt. cap
8.72 сая
Avg. vol.
2.94 мян
Volume
0.00
52-wk high
€ 0.06
52-wk low
€ 0.00
News stories
From web sources and news partners
About Revive Therapeutics Ltd
CEO-
Employees-
Founded2012
HeadquartersТоронто, Онтарио, Канад
SectorPharmaceutical industry
Websiterevivethera.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 оны 6-р сар
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
336.32 мян
200.14 мян
283.25 мян
242.05 мян
Operating expense
336.39 мян
220.13 мян
283.30 мян
463.87 мян
Total operating expenses
336.39 мян
220.13 мян
283.30 мян
463.87 мян
Operating income
-336.39 мян
-220.13 мян
-283.30 мян
-463.87 мян
Other non operating income
73.85 мян
-
-
-
EBT including unusual items
-9.60 сая
-281.75 мян
-238.72 мян
-506.50 мян
EBT excluding unusual items
-143.94 мян
-281.75 мян
-234.70 мян
-506.50 мян
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.60 сая
-281.75 мян
-238.72 мян
-506.50 мян
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
277.00
-
-
Interest expense
-
-
-
-
Net interest expenses
-
277.00
-
-
Depreciation and amortization charges
62.00
46.00
48.00
47.00
EBITDA
-336.32 мян
-220.08 мян
-283.25 мян
-463.82 мян
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google аппс